Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Allergan, which is headquartered in Dublin, Ireland and operates four facilities in Ireland, has announced a EUR 65-million ($73-million) capital investment program for 2019 to facilitate the continued expansion of the company’s laboratories and...

Merck & Co. has approved a new global restructuring program, at a cost of $800 million to $1.2 billion, as part of a global initiative focused primarily on further optimizing the company’s manufacturing and supply network as well as reducing...

In tracking approvals of new molecular entities, Johnson & Johnson's Janssen Pharmaceutical gains FDA approval for Balversa (erdafitinib) for treating metastatic bladder cancer and Amgen gets the FDA nod for Evenity (romosozumab-aqqg)...

Novartis has appointed Richard Saynor as Chief Executive Officer (CEO) of Sandoz, the company’s biosimilars and generics business, effective no later than August 1, 2019. He will be a member of the Executive Committee of Novartis and report to Vas...

Kite, part of Gilead Sciences, has announced plans for a new facility in Frederick County, Maryland, which will produce cell therapies for treating cancer. The 20-acre site will expand Kite’s ability to manufacture a variety of chimeric antigen...

Regeneron Pharmaceuticals, a Tarrytown, New York-based biopharmaceutical company, and Alnylam Pharmaceuticals, a Cambridge, Massachusetts-based company developing RNA interference (RNAi) therapeutics, have formed a collaboration, worth up to $1...